Indian Immunologicals clocks all-time high revenue of Rs 1,586 crore in FY26
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The launch coincides with IBS Awareness Month in April
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
Subscribe To Our Newsletter & Stay Updated